NASDAQ:ANGO - AngioDynamics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$20.92 +0.01 (+0.05 %)
(As of 10/18/2018 10:30 AM ET)
Previous Close$20.91
Today's Range$20.77 - $20.97
52-Week Range$15.16 - $24.49
Volume5,605 shs
Average Volume245,999 shs
Market Capitalization$806.02 million
P/E Ratio28.27
Dividend YieldN/A
Beta0.86
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. It also offers thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. In addition, the company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; and Asclera injection for treating uncomplicated spider and reticular veins of the lower extremities. Further, it provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation system; and radiofrequency ablation products for ablating solid cancerous or benign tumors. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Receive ANGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ANGO
CUSIP03475V10
Phone518-795-1400

Debt

Debt-to-Equity Ratio0.16
Current Ratio2.64
Quick Ratio1.55

Price-To-Earnings

Trailing P/E Ratio28.27
Forward P/E Ratio24.61
P/E GrowthN/A

Sales & Book Value

Annual Sales$344.29 million
Price / Sales2.26
Cash Flow$1.3274 per share
Price / Cash15.76
Book Value$14.74 per share
Price / Book1.42

Profitability

EPS (Most Recent Fiscal Year)$0.74
Net Income$16.33 million
Net Margins4.62%
Return on Equity5.44%
Return on Assets4.18%

Miscellaneous

Employees1,145
Outstanding Shares37,120,000
Market Cap$806.02 million

AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) issued its earnings results on Thursday, September, 27th. The medical instruments supplier reported $0.16 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by $0.02. The medical instruments supplier earned $85.34 million during the quarter, compared to analyst estimates of $84.05 million. AngioDynamics had a net margin of 4.62% and a return on equity of 5.44%. The business's revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter last year, the company posted $0.13 EPS. View AngioDynamics' Earnings History.

When is AngioDynamics' next earnings date?

AngioDynamics is scheduled to release their next quarterly earnings announcement on Thursday, January 3rd 2019. View Earnings Estimates for AngioDynamics.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY19 earnings guidance on Thursday, September, 27th. The company provided EPS guidance of $0.82-0.86 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.85. The company issued revenue guidance of $354-359 million, compared to the consensus revenue estimate of $350.34 million.

What price target have analysts set for ANGO?

4 equities research analysts have issued 12-month price targets for AngioDynamics' stock. Their forecasts range from $16.33 to $20.00. On average, they anticipate AngioDynamics' stock price to reach $18.1650 in the next year. This suggests that the stock has a possible downside of 13.1%. View Analyst Price Targets for AngioDynamics.

What is the consensus analysts' recommendation for AngioDynamics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for AngioDynamics.

Who are some of AngioDynamics' key competitors?

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the folowing people:
  • Mr. James C. Clemmer, CEO, Pres & Director (Age 54)
  • Mr. Michael C. Greiner, Exec. VP & CFO (Age 45)
  • Mr. David D. Helsel, Sr. VP of Global Operations and R&D (Age 54)
  • Mr. Stephen A. Trowbridge, Sr. VP, Gen. Counsel & Assistant Sec. (Age 44)
  • Mr. Robert A. Simpson, Sr. VP & GM of Peripheral Vascular Global Bus. Unit (Age 46)

Who are AngioDynamics' major shareholders?

AngioDynamics' stock is owned by a number of of institutional and retail investors. Top institutional investors include Tributary Capital Management LLC (1.34%), Foundry Partners LLC (0.95%), Tributary Capital Management LLC (0.86%) and Bank of Montreal Can (0.20%). Company insiders that own AngioDynamics stock include Avista Capital Partners Gp, Ll, James C Clemmer and Jan Stern Reed. View Institutional Ownership Trends for AngioDynamics.

Which institutional investors are selling AngioDynamics stock?

ANGO stock was sold by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC and Foundry Partners LLC. View Insider Buying and Selling for AngioDynamics.

Which institutional investors are buying AngioDynamics stock?

ANGO stock was acquired by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC and Bank of Montreal Can. Company insiders that have bought AngioDynamics stock in the last two years include James C Clemmer and Jan Stern Reed. View Insider Buying and Selling for AngioDynamics.

How do I buy shares of AngioDynamics?

Shares of ANGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $20.90.

How big of a company is AngioDynamics?

AngioDynamics has a market capitalization of $806.02 million and generates $344.29 million in revenue each year. The medical instruments supplier earns $16.33 million in net income (profit) each year or $0.74 on an earnings per share basis. AngioDynamics employs 1,145 workers across the globe.

What is AngioDynamics' official website?

The official website for AngioDynamics is http://www.angiodynamics.com.

How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected]


MarketBeat Community Rating for AngioDynamics (NASDAQ ANGO)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  322 (Vote Underperform)
Total Votes:  578
MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe ANGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2018 by MarketBeat.com Staff

Featured Article: Market Capitalization

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel